Tell the FDA WTF Is Up with CBD (As Long as You Do It Nicely)

By Josh Jardine for The Stranger

I wish we could sway federal policy with patient stories—and, to a degree, we can on Capitol Hill—but with a regulatory body like the FDA, they’re looking for very specific answers to very specific questions. It’s not like an up/down vote on how many comments in favor and how many comments against [CBD products]. It’s based off the quality and content of the comments.” -David Mangone